drugset / Trial / NCT02798510

Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma

NCT02798510 ↗

Phase 3 Unknown 140 enrolled Fudan University
RandomizedParallel-groupOpen-labelTreatment

Summary

The present study is designed to determine whether adjuvant concurrent chemoradiotherapy improves overall survivals.

Timeline

Start
2016-04
Primary completion
2019-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule 1330 mg/m2 —
Subject Capecitabine Small molecule 1500 mg/m2 —
Subject Gemcitabine Small molecule 1000 mg/m2 Intravenous